The Canadian Diabetes Association has released the 2008 edition of the clinical practice guidelines for the prevention and management of diabetes in Canada.
Santhera Pharmaceuticals is introducing Catena for the symptomatic management of patients with Friedreich's ataxia, which is a rare, progressive neuromuscular disease.
In October, Novartis expects to launch Tasigna for the treatment of chronic myeloid leukemia in adults who have developed resistance or intolerance to at least one prior therapy, including imatinib.